J. Safra Sarasin Holding AG
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1890222
BASEL, V8
Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$409,042
-$885,865 QoQ
Shares Held
656
-71.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#857
of 1,322 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $38,071,978 across 30 Biotechnology names. REGN ranks #21 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
95,602 | $10,193,085 | |
| 2 | INCY |
Incyte Corp
|
29,655 | $3,361,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,921 | $2,384,458 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,195 | $2,083,782 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
47,662 | $2,045,176 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
107,839 | $1,981,002 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
49,694 | $1,758,670 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,662 | $1,719,217 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $409,042 | 656 | Shares | Defined | 2026-07-31 | |
| 2025-09-30 | $1,294,907 | 2,303 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $295,050 | 562 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $634,230 | 1,000 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,226,030 | 3,125 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||